Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
101.72B | 99.94B | 93.85B | 80.79B | 86.96B | 110.50B | Gross Profit |
15.59B | 15.65B | 15.27B | 14.36B | 10.86B | 14.08B | EBIT |
3.48B | 3.67B | 3.09B | 3.32B | 569.00M | 2.41B | EBITDA |
7.38B | 9.17B | 8.24B | 8.08B | 5.22B | 4.08B | Net Income Common Stockholders |
588.00M | 1.11B | -1.68B | 1.32B | -125.00M | -4.01B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.14B | 3.11B | 3.71B | 5.06B | 4.25B | 4.67B | Total Assets |
118.11B | 111.54B | 100.11B | 96.92B | 93.89B | 90.40B | Total Debt |
48.43B | 39.78B | 36.70B | 36.15B | 37.44B | 34.53B | Net Debt |
44.29B | 36.67B | 32.99B | 31.09B | 33.19B | 29.86B | Total Liabilities |
79.72B | 70.94B | 67.91B | 65.00B | 65.50B | 63.67B | Stockholders Equity |
37.45B | 39.72B | 31.43B | 31.06B | 27.56B | 25.84B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.14B | -1.26B | 1.72B | -3.65B | -5.07B | Operating Cash Flow |
0.00 | 2.97B | 4.88B | 5.08B | 318.00M | 2.39B | Investing Cash Flow |
0.00 | -5.05B | -5.44B | -2.37B | -2.88B | -7.00B | Financing Cash Flow |
0.00 | 1.25B | -940.00M | -2.47B | 2.22B | 3.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥8.02B | 2.72 | 3.64% | 2.17% | 66.19% | ||
76 Outperform | ¥9.53B | 4.42 | 4.93% | 1.49% | 93.90% | ||
73 Outperform | ¥10.10B | 5.58 | 3.09% | -4.87% | -19.12% | ||
70 Outperform | ¥8.58B | 6.02 | 5.00% | 0.69% | 7.21% | ||
62 Neutral | $6.84B | 11.41 | 2.80% | 3.87% | 2.70% | -24.58% | |
53 Neutral | ¥8.14B | ― | 2.79% | -3.96% | -462.49% | ||
51 Neutral | ¥8.82B | ― | 3.25% | 24.16% | 93.48% |